Immunoglobulin G4-related disease (IgG4-RD) is increasingly recognized as an autoimmune disease, involvement of multi-organ or system, which is characterized by tissue infiltration of IgG4-positive plasma cells and elevated serum IgG4. We reported a case of 54-year-old man with a medical history of uarthritis, virus B hepatitis, autoimmune pancreatitis, cholecystitis, pulmonary lesion and acute renal failure. The patient was diagnosed with multi-system IgG4-RD based on histological analysis of the renal biopsy revealed IgG4-positive plasmacyte infiltration, elevated serum IgG4(6.95g/L).Corticosteroids(methylprednisolone 250mg/d for 3 days subsequently 40 mg/d) and cyclophosphamide (0.8g iv per month) were used. Not only the IgG4 levels returned to normal but also patient's renal dysfunction and pulmonary lesions relieved after treatment.
INTRODUCTION
IgG4 related disease (IgG4-RD) is a multi-organ immune-mediated condition that mimics many malignant, infectious, and inflammatory disorders (1) . Many organs or systems can be involved, including pancreas, gall bladder, bile duct, salivary glands, thyroid gland, lymphnodes, kidney, lung, liver, retroperitoneum and aorta (2) . The etiology and mechanism of this disease is unclear3. The clinical manifestations are protean, without characteristic symptoms and signs at the early stage, which leads to misdiagnose.Tissue biopsy is the gold standard for diagnosis (1) . The current treatment for IgG4-RD is corticosteroids and rituximab. Cyclophosphamide had been reported to treat IgG4-RD, however, the result was not satisfactory (4, 5) . In this report, we describe an IgG4-RD patient with multiple organs involvement successfully treated with combination of corticosteroids and cyclophosphamide.
CASE REPORT
A 54-year-old Chinese man had a past medical history of uarthritis and virus B hepatitis. He was admitted to hospital with the chief complaint of stomachache and jaundicein April 2014.Abdominal ultrasonography and magnetic resonance cholangiopancreatography (MRCP, level without severe adverse effect. We found that reason may be the shorter disease duration and lower immunoglobulin level of our case. Therefore, based on the experience from this case, we think cyclophosphamide could be recommended for IgG4-RD patients with severe multiple organs involvement. However, large-scale and multicenter clinical trials should be adopted to further confirm its effectiveness and safety.
CONCLUSION
IgG4-RD is a chronic progressive autoimmune disease, eventually leading to tissue fibrosis and organ dysfunction, which affect the prognosis of patients. In order to delay the progress of the disease, early diagnosis and timely treatment are critical. Doctors need to raise awareness of the disease, especially in those with symptoms and signs of multiple organs involvement. Biopsy of lesions is the gold standard of diagnosis, which should be performed timely in patients suspected with this disease. Corticosteroids combined with cyclophosphamide may be a reasonable alternative in the treatment of IgG4-RD.
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